Schizophrenia Drugs Market Showing Impressive Growth by 2026

[Ankit Dwivedi]

The increasing prevalence of chronic and mental disorder is a key factor expected to enable growth in the global schizophrenia drugs market, says Fortune Business Insights in a report, titled “Schizophrenia Drugs Market Size, Share & Industry Analysis, By Therapeutic Class (Second Generation, Third Generation, Others), By Treatment (Oral, Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others) and Regional Forecast, 2019-2026.” The global schizophrenia drugs market was valued at USD 6.75 Billion in 2018 and is projected to reach USD 9.48 Billion by 2026, exhibiting a CAGR of 4.3% during the forecast period.

To gain more insights into the market, click here: https://www.fortunebusinessinsights.com/industry-reports/schizophre...

Key Segmentation of Schizophrenia Drugs Market:

Schizophrenia Drugs Market Segments by Therapeutic Class

• Second Generation
• Third Generation
• Others

Schizophrenia Drugs Market Segments by Treatment

• Oral
• Injectable

Schizophrenia Drugs Market Segments by Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Others

By Geography

• North America (U.S. and Canada)
• Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
• Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
• Latin America (Brazil, Mexico, and Rest of Latin America)
• Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)

Bone Growth Stimulators Market

Cataract Surgical Devices Market

Neuromodulation Devices Market

Population Health Management Market

Smart Inhalers Market

Legionella Testing Market

Sleep Apnea Devices Market

Impact of COVID-19 on the Medical Devices Market

Gene Therapy Market

Diabetes Treatment Devices Market

Veterinary Imaging Market